文献速递甲状腺与浅表介入US

超声引导射频消融治疗甲状腺微小乳头状癌的疗效及影响因素分析

Analysis of Therapeutic Effect and Influencing Factors of Ultrasound-Guided Radiofrequency Ablation in the Treatment of Papillary Thyroid Microcarcinoma.
PubMed 文献 · J Ultrasound Med · 2023-03-07

该研究比较了超声引导射频消融与手术治疗甲状腺微小乳头状癌的效果,发现消融组手术相关指标更优、病灶体积缩小更明显、复发累积发生率更低,且TSH和TgAb是射频消融后复发的独立危险因素。

要点

  • 超声引导射频消融治疗PTMC术后6个月病灶体积缩小率高于手术组。
  • 消融组复发累积发生率更低,TSH和TgAb为复发独立危险因素。
  • 消融组甲状腺功能相关指标术前术后无显著差异。

诊断标准与关键数值

  • 观察组术后第6个月病灶体积低于对照组,体积缩小率高于对照组。
  • 观察组术后血清TSH、炎症因子和TgAb水平均降低,FT3和FT4水平升高,均优于对照组。
  • 观察组术后复发累积发生率低于对照组。
  • TSH和TgAb被确定为PTMC患者射频消融后复发的独立危险因素。

临床应用与阅片要点

  • 对于PTMC患者,超声引导射频消融可作为手术之外的微创治疗选择。
  • 术后随访应关注TSH和TgAb水平,评估复发风险。
  • 消融术后需定期测量病灶体积,计算体积缩小率以评价疗效。

局限性

  • 随访时间仅6个月,长期疗效和复发情况有待进一步观察。
  • 研究设计为单中心对照研究,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The current study sought to explore the effects of ultrasound (US)-guided radiofrequency ablation (RFA) on papillary thyroid microcarcinoma (PTMC) and influencing factors.

METHODS: PTMC patients were assigned to observation (US-guided RFA) and control (surgical operation) groups. A series of operation-related indexes (operation time, intraoperative bleeding, wound closure time, hospital stay, and expenses), visual analogue scale score, lesion size, and thyroid function-related indexes (thyroid-stimulating hormone [TSH], free triiodothyronine*** [FT3], free thyroxine [FT4]), inflammatory factors, and thyroglobulin antibody (TgAb) were assessed and compared. After a 6-month follow-up period, the complications and recurrence were recorded, in addition to analyses of postoperative recurrence cumulative incidence and evaluation of recurrence risk factors.

RESULTS: Operation-related indexes of the observation group were relatively decreased compared with the control group. In addition, the lesion volume in the observation group was lower compared to that in the control group at the 6th month after operation, whereas the volume reduction rate was higher. There were no significant differences in regard to thyroid function-related indexes in the observation group before/after operation. After operation, serum TSH levels and inflammatory factors, and TgAb levels were all diminished, while the FT3 and FT4 levels were both elevated in the observation group relative to the control group, and postoperative recurrence cumulative incidence was lower in the observation group. TSH and TgAb were established as the independent risk factors for recurrence after RFA in PTMC patients.

CONCLUSIONS: Our findings highlighted that US-guided RFA exhibits better efficacy, safety, and postoperative recovery and lower recurrence risk for PTMC.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Zeng, Zou, Chen, et al. Analysis of Therapeutic Effect and Influencing Factors of Ultrasound-Guided Radiofrequency Ablation in the Treatment of Papillary Thyroid Microcarcinoma. J Ultrasound Med. 2023. PMID: 36880705. doi:10.1002/jum.16197

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。